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Affinity purification of the opioid receptor in NG 108-15 cells was carried out using an affinity resin based 
on the avidin-biotin interactions, but a new elution method was employed with a radioligand of sub-micro- 
molar concentration. A synthesized biotinyl derivative of leucine-enkephalin has a high affinity for the 6- 
receptor, but the affinity was lowered IO-fold in the presence of avidin. The new elution method is based 
on this affinity decrease and resulted in a IOO-fold purification over the initial crude materials in the single 
step. SDS-polyacrylamide gel electrophoresis of the purified receptor revealed three polypeptides of 58, 65 
and 71 kDa as possible components of the a-receptor. 
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1. INTRODUCTION 
The existence of several different types of opioid 
receptor - p, 6 and x, at least - has been estab- 
lished. However, the molecular entity of the recep- 
tors is still an open question, although several 
attempts have made some progress in the studies of 
p- as well as &receptors by solubilization/purifica- 
tion [l-4] and by affinity labeling [5-g]. Affinity 
chromatography is a technique of considerable im- 
f To whom correspondence should be addressed 
Abbreviations: biocytinamide, JV-biotinyllysine amide; 
Boc, t-butyloxycarbonyl; EDC HCI, l-ethyl-3-(3- 
dimethylaminopropyl)carbodiimide hydrochloride; 
HOBt, 1-hydroxy-benztriazole; TFA, trifluoroacetic 
acid; CHAPS, 3-[(3-cholamidopropyl)dimethylamino]- 
I-propanesulfate; DADLE, [D-Ala’,D-Leu’]-enkeph- 
alin 
portance in the isolation of the receptors con- 
cerned, since active receptor molecules are 
necessary to assess the functional reconstitution of 
the isolated receptors. The receptor-ligand interac- 
tion is strong in general, with nanomolar range of 
affinity: that is the case in the opioid receptor 
system. Therefore, a large excess ligand (more than 
micromolar concentration) was used to elute the 
opioid or opiate receptor from the affinity column 
[4,10], and the activity of the eluted receptor was 
measured only after extensive removal of the elu- 
tion ligand by gel filtration or dialysis. We 
developed a new technique of affinity chroma- 
tography using an avidin-biotin system, in which a 
mild elution with radioligand of reasonable con- 
centrations (sub-micromolar) makes it possible to 
perform the immediate binding assay after the elu- 
tion. We report here an application of this method 
for a single-step purification of the opioid receptor 
in NG 108-15 cells. 
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2. MATERIALS AND METHODS 
2. I. Synthesis of [(leucine-enkephalinyl- 
hydrazido)succinylJbiocytinamide 1 
The biotinyl analog of leucine-enkephalin 1 was 
synthesized according to the following procedures. 
Biocytinamide [l l] was treated with succinic 
anhydride. The succinylated material was coupled 
with N”-Boc-leucine-enkephalin hydrazide by 
EDC HCl and HOBt, followed by removal of the 
Boc group with TFA. Composition of the product 
was verified by amino acid analysis (Tyr/Gly/Phe/ 
Leu/Lys = 1.00:2.00: 1.05: 1.00: 1.04) and a 
single elution peak was observed by HPLC 
analysis. 
2.2. Solubilization of NG 108-15 cells and 
receptor binding assay 
NG 108-15 cells were grown and harvested as 
described [ 12,131. The cell suspension in 0.3 M 
sucrose-25 mM Hepes-KOH (pH 7.5) was 
homogenized with a Polytron PT-10 [14] and 
solubilized in 10 mM CHAPS as described [l] with 
a slight modification. The solubilized receptor 
(1 ml) in 50 mM Hepes-KOH plus 10 mM MgS04 
buffer (pH 7.5) [buffer A] containing 2 mM 
CHAPS and bacitracin (0.1 mg/ml) was incubated 
for 2 h at 37°C with 8 nM [3H]DADLE and 
various concentrations of ligand 1. When avidin 
was to be added, its molar ratio to 1 was main- 
tained at 1: 4 since one avidin molecule is able to 
bind four biotins. The incubation was terminated 
by a rapid filtration of the sample aliquots (in 
duplicate) through a nitrocellulose filter (25 mm 
diameter) under vacuum [ 151. The filter was 
washed three times with 3 ml cold buffer A. When 
column fractions were assayed, the [3H]DADLE 
concentration was 100 nM: it was added to the 
passed-through fractions while the fractions eluted 
with 100 nM [3H]DADLE were assayed directly. 
Nonspecific binding of radioligand was measured 
in the presence of 1OObM [D-Ala’]leucine- 
enkephalin. 
3. RESULTS 
3.1. Binding characteristics 
ligand 
The synthesized biotinyl 
of the biotinylated 
analog of leucine- 
enkephalin 1 was tested in a receptor displacement 
assay against [3H]DADLE, as shown in fig.1. 
Compound 1 had an ICSO value of 50 nM in the 
absence of avidin. Its Kd value was calculated to be 
12 nM from the following equation: 
ICso = &(l + [L]/KL) (1) 
where ICSO = 50 nM, [L] represents the concentra- 
tion of [3H]DADLE used (8 nM) and KL the 
dissociation constant of [3H]DADLE (2.6 nM, ob- 
tained from a separate experiment, which agreed 
well with the reported value [16]). The Kd value ob- 
tained was in close agreement with that of leucine- 
enkephalin (5 nM [17]). In the presence of avidin, 
ICSO = 650 nM or Kd = 159 nM was obtained. 
These data show that the affinity of 1 was de- 
creased 13-fold in the presence of avidin, as 
demonstrated by Koman and Terenius [18] in 
analogous compounds. 
3.2. Purification of opioid receptors from NG 
108-15 cells 
The receptor-biotinyl ligand complex formed by 
incubating the solubilized receptor and 1 was 
separated by affinity chromatography with an 
avidin-conjugated agarose. A large excess of 1 
(3 PM) over the receptor sites (2.2 nM) was used to 
facilitate rapid and complete complex formation. 
The incubation mixture was poured into an avidin- 
agarose column and circulated through the col- 
umn. After crude receptor preparation passed 
through, the DADLE binding activity (31Yo) re- 
tained by the column was eluted in the presence of 
100 nM [3H]DADLE (fig.2). The overall recovery 
of activity was 2.3%, but the specific activity of 
fractions eluted with [3H]DADLE was 27.2 pmol 
per mg of protein (table 1); a lOO-fold purification 
over the initial solubilized preparation was 
achieved. 
3.3. SDS gel electrophoresis 
Samples at different purification steps were 
analyzed by SDS gel electrophoresis (fig.3). The 
gel pattern of the materials eluted with 100 nM 
r3H]DADLE shows three bands, with molecular 
masses of 58, 65 and 71 kDa, which are observed 
in the solubilized preparation (starting material) 
but hardly in the passed-through fraction. 
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Fig. 1. Displacement curves of the synthesized biotinyl analog of leucine-enkephalin 1 (0) and 1 + avidin 4 : 1 ( q ), using 
8 nM [3H]DADLE as radioligand. Nonspecific binding of [‘HIDADLE in the absence (---) and presence (x) of 
avidin is indicated. The nonspecific binding in the latter case showed dose-dependency of avidin and the corrected 
displacement curve for 1 + avidin (m) is also indicated after normalizing the nonspecific binding components (x-x) 
to the broken line level. 
Table 1 
Purification of DADLE-binding protein 
[3H]DADLE Protein 
bounda (mg) 
(pmo]) 
Specific 
activityb 
% initial 
binding 
activity 
Solubilized 
preparation 22.3 89.5 0.25 100 
100 nM [3H]- 
DADLE eluate 0.503 0.0185 27.2 2.3 
a Binding activities were measured at 100 nM [‘HIDADLE 
b Expressed as pmol of [3H]DADLE bound per mg of protein 
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Fig.2. Elution profile from an affinity column. The 
solubilized crude receptor was incubated with 3 FM 1 for 
3.5 h at 4”C, and the mixture was applied to an avidin- 
agarose column (2 ml) and circulated through the 
column for 2 h at 4°C. The column was washed with 
buffer A containing 2 mM CHAPS and three proteinase 
inhibitors (1 mM iodoacetamide, 0.1 mM phenylmethyl- 
sulfonyl fluoride, and 1 PM pepstatin A), and then 
eluted with the buffer containing 100 nM [3HJDADLE. 
Buffer was changed where indicated and 2 ml fractions 
were collected. 
4. DISCUSSION 
The biotinylated enkephalin ligand 1 retains a 
sufficient affinity for the receptor (& = 12 nM), 
compared with that of leucine-enkephaliR (& = 
5 nM), the parent compound, although a sub- 
stantial size of succinyl biocytinamide moiety was 
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Fig.3. SDS-polyacrylamide gel (100) electrophoresis of 
the column fractions in fig.2 under reducing conditions 
(50 mM dithiothreitol). Lanes: A, solubilized 
preparation that poured into the column (2.7pg); B, 
fraction 6 (1.2pg); C, fraction 19 and 20 eluted with 
100 nM 13H]DADLE (0.35 rg). The gel was silver- 
stained. 
R.receptor , L-B biotinyl ligand , A-P avidin-agarose 
Fig.4. A schematic illustration of the receptor-ligand 
interaction on the avidin-agarose. 
introduced. In the presence of avidin the affinity 
of 1 decreased 13-fold, probably due to a steric 
hindrance evoked on the two macromolecules, 
receptor and avidin, in which a rather small 
molecule 1 intervenes. This character of affinity 
decrease was utilized for the novel elution method 
presented here. 
Fig.4 illustrates schematically the idea of this 
method. Applications of the avidin-biotin system 
to the affinity purification of hormone receptors 
have been pioneered by Hofmann and his col- 
leagues [19,20]. Major problems seem to exist at 
the elution step where one tries to cleave the in- 
teraction at site 1 in fig.4, which is very strong in 
general (Kd = 10-r’ M). The present method de- 
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rived from Hofmann’s initial works is directed to 
cleave at site 2, where i(d is in the range of 10M9 M 
in most of the receptor systems and is expected to 
increase (affinity decrease), in the presence of 
avidin, as demonstrated above. 
At elution with [3H]DADLE, we assumed that a 
single ligand displacement from 1 to [3H]DADLE 
occurs on the receptor molecule which was re- 
tained on the avidin-agarose. The concentration of 
[3H]DADLE required to elute half of the receptor 
was calculated to be 52 nM using eqn 1, where Kd 
for ~3H]DADLE is 2.6 nM, [L] represents the con- 
centration of 1 used (3 nM) and I&, the dissociation 
constant of 1 in the presence of avidin (159 nM). 
Using 100 nM i3H]DADLE in this case, the opioid 
receptor was eluted and a lOO-fold purification 
over the initial preparation was achieved. 
The eluted materials contain three potypeptides 
of 58,65 and 71 kDa as shown by SDS-PAGE. NG 
108-15 cells are known to carry only a single type 
of opioid receptor, with S-subtype characteristics 
[14], and the three poiypeptides demonstrated here 
must be candidates for the &receptor components. 
The 58 kDa polypeptide is one of the most 
probable d-receptor component in NG 108-15 
cells, as previously demonstrated by affinity 
labeling [6] and by photoaffinity labeling [9]. 
While affinity decrease of the biotinyl ligand for 
the receptor, which was brought about in the 
presence of avidin, is an advantage for eluting the 
receptor with ligands of low concentration, it is a 
defect in terms of receptor recovery. As shown in 
fig.2, a significant amount of receptor activity was 
not retained on the column. However, the elution 
with radioligand of reasonable concentrations 
followed by an immediate binding assay can com- 
pensate for the drawback, particularly in labile 
receptor systems. It could be expected that, in most 
receptor systems, the affinity of the receptor- 
biotinyl ligand complex will be decreased by 
avidin-agarose. This method may therefore be 
widely applicable to the purification of receptors. 
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